Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aschan

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Clinical Transplantation|May 12, 1998
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontaminationS Carlens, O Ringdén, J Aschan, et al.
Journal of Hematotherapy & Stem Cell Research|August 31, 2002
Cytolytic T cell reactivity to Epstein-Barr virus is lost during in vitro T cell expansionS Carlens, D Liu, O Ringdén, et al.
Bone Marrow Transplantation|August 24, 1999
Unrelated donor stem cell transplantation after autologous transplantation: experience of a single centerJ Aschan, M Remberger, S Carlens, et al.
Bone Marrow Transplantation|November 20, 2002
The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donorsM Remberger, J Mattsson, P Hentschke, et al.
British Journal of Haematology|February 15, 2002
Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantationJ Mattsson, M Uzunel, M Brune, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 1996
Oral ribavirin for prevention of severe liver disease caused by hepatitis C virus during allogeneic bone marrow transplantationP Ljungman, J Andersson, J Aschan, et al.
Bone Marrow Transplantation|April 21, 2001
Pharmacokinetics of liposomal busulphan in manZ Hassan, P Ljungman, O Ringdén, et al.
Bone Marrow Transplantation|May 1, 1997
Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infectionsE Sparrelid, P Ljungman, E Ekelöf-Andström, et al.
Therapeutic Drug Monitoring|August 15, 2000
Ketobemidone may alter busulfan pharmacokinetics during high-dose therapyM Hassan, J O Svensson, C Nilsson, et al.
Bone Marrow Transplantation|March 5, 1998
Transplantation with unrelated bone marrow in leukaemic patients above 40 years of ageO Ringdén, M Remberger, J Mattsson, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Clinical Transplantation|May 12, 1998
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontaminationS Carlens, O Ringdén, J Aschan, et al.
Journal of Hematotherapy & Stem Cell Research|August 31, 2002
Cytolytic T cell reactivity to Epstein-Barr virus is lost during in vitro T cell expansionS Carlens, D Liu, O Ringdén, et al.
Bone Marrow Transplantation|August 24, 1999
Unrelated donor stem cell transplantation after autologous transplantation: experience of a single centerJ Aschan, M Remberger, S Carlens, et al.
Bone Marrow Transplantation|November 20, 2002
The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donorsM Remberger, J Mattsson, P Hentschke, et al.
British Journal of Haematology|February 15, 2002
Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantationJ Mattsson, M Uzunel, M Brune, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 1996
Oral ribavirin for prevention of severe liver disease caused by hepatitis C virus during allogeneic bone marrow transplantationP Ljungman, J Andersson, J Aschan, et al.
Bone Marrow Transplantation|April 21, 2001
Pharmacokinetics of liposomal busulphan in manZ Hassan, P Ljungman, O Ringdén, et al.
Bone Marrow Transplantation|May 1, 1997
Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infectionsE Sparrelid, P Ljungman, E Ekelöf-Andström, et al.
Therapeutic Drug Monitoring|August 15, 2000
Ketobemidone may alter busulfan pharmacokinetics during high-dose therapyM Hassan, J O Svensson, C Nilsson, et al.
Bone Marrow Transplantation|March 5, 1998
Transplantation with unrelated bone marrow in leukaemic patients above 40 years of ageO Ringdén, M Remberger, J Mattsson, et al.
Pageof 7